Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
8x8 Inc
EGHT
$269M
| $2.92M | ﹤0.01% |
1,314,970
+96,888
| +8% | +$236K |
|
2577
Kura Sushi USA
KRUS
$560M
| $2.91M | ﹤0.01% |
46,110
+1,465
| +3% | +$148K |
|
2578
OmniAb
OABI
$287M
| $2.89M | ﹤0.01% |
771,303
+14,416
| +2% | +$65.7K |
|
2579
Fate Therapeutics
FATE
$286M
| $2.88M | ﹤0.01% |
879,375
-76,956
| -8% | -$337K |
|
2580
Neumora Therapeutics
NMRA
$298M
| $2.86M | ﹤0.01% |
291,364
+166,822
| +134% | +$1.73M |
|
2581
Planet Labs
PL
$7.3B
| $2.85M | ﹤0.01% |
1,531,462
+23,399
| +2% | +$44.9K |
|
|
ENFN
2582
DELISTED
Enfusion, Inc.
ENFN
| $2.84M | ﹤0.01% |
333,769
+32,209
| +11% | +$295K |
|
2583
Alerus Financial
ALRS
$831M
| $2.83M | ﹤0.01% |
144,096
+2,542
| +2% | +$50.1K |
|
2584
Lindblad Expeditions
LIND
$1.94B
| $2.82M | ﹤0.01% |
292,699
+8,448
| +3% | +$65.4K |
|
|
NPKI
2585
NPK International
NPKI
$1.06B
| $2.82M | ﹤0.01% |
339,368
-7,155
| -2% | -$55.1K |
|
2586
Lightwave Logic
LWLG
$995M
| $2.81M | ﹤0.01% |
940,752
+84,378
| +10% | +$308K |
|
|
EWCZ
2587
DELISTED
European Wax Center
EWCZ
| $2.81M | ﹤0.01% |
282,850
+7,616
| +3% | +$86.5K |
|
2588
U-Haul Holding Co
UHAL
$13.9B
| $2.77M | ﹤0.01% |
44,904
-6,493
| -13% | -$423K |
|
2589
Funko
FNKO
$326M
| $2.76M | ﹤0.01% |
283,016
+1,389
| +0.5% | +$10.8K |
|
2590
Anavex Life Sciences
AVXL
$255M
| $2.75M | ﹤0.01% |
651,084
+21,017
| +3% | +$85K |
|
2591
Allogene Therapeutics
ALLO
$649M
| $2.75M | ﹤0.01% |
1,178,401
+319,925
| +37% | +$944K |
|
|
GPMT
2592
Granite Point Mortgage Trust
GPMT
$69M
| $2.74M | ﹤0.01% |
921,257
-183,333
| -17% | -$679K |
|
2593
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
| $2.73M | ﹤0.01% |
54,935
-39,948
| -42% | -$1.98M |
|
2594
Tyra Biosciences
TYRA
$1.9B
| $2.72M | ﹤0.01% |
169,945
+17,733
| +12% | +$305K |
|
|
FFWM
2595
DELISTED
First Foundation Inc
FFWM
| $2.71M | ﹤0.01% |
413,212
+8,827
| +2% | +$54.1K |
|
|
OPTU
2596
Optimum Communications Inc
OPTU
$298M
| $2.69M | ﹤0.01% |
1,316,380
+9,171
| +0.7% | +$20.4K |
|
2597
Oil States International
OIS
$489M
| $2.68M | ﹤0.01% |
604,677
-175,285
| -22% | -$843K |
|
2598
Pacific Biosciences
PACB
$435M
| $2.68M | ﹤0.01% |
1,957,496
-30,023
| -2% | -$60.6K |
|
2599
Rayonier Advanced Materials
RYAM
$604M
| $2.67M | ﹤0.01% |
490,588
-85,414
| -15% | -$415K |
|
2600
MediaAlpha
MAX
$758M
| $2.66M | ﹤0.01% |
202,268
+29,090
| +17% | +$535K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.